Want to see SE:NNH full AI Analyst Report?
NNH Stock Chart & Stats
kr12.35
kr0.00(0.00%)
At close: 4:00 PM EDT
kr12.35
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr11.60 - kr26.00
Previous CloseN/A
Volume1.66K
Average Volume (3M)9.89K
Market Cap
kr103.46M
Enterprise Valuekr102.11
Total Cash (Recent Filing)kr9.91M
Total Debt (Recent Filing)kr37.06M
Price to Earnings (P/E)13.1
Beta0.39
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.5%
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,195,200
10 Day Avg. Volume12,292
30 Day Avg. Volume9,888
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.39
Price to Sales (P/S)0.25
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Branded Health PortfolioA branded nutraceutical portfolio can support customer recognition, repeat purchasing, and differentiated pricing across health and wellness categories. Selling through retail, pharmacy, and distribution channels also gives NNH several routes to market and supports broader product reach over time.
Return To ProfitabilityThe return to positive EBIT and net income, alongside continued revenue growth since 2022, indicates that the business has regained operating traction. If this recovery persists, improving scale and commercial execution could strengthen earnings capacity over the next several quarters.
Manageable LeverageDebt at roughly one-third of equity provides a relatively manageable leverage position and preserves financial flexibility compared with a highly indebted balance sheet. Positive TTM return on equity further indicates that the capital base is again generating returns after prior weak periods.
Bears Say
Thin ProfitabilityVery thin operating and net margins leave limited protection if costs rise or pricing weakens. The losses recorded from 2022 through 2024 also show that earnings recovery has not yet demonstrated durable resilience, making future results sensitive to relatively small operating changes.
Uneven Cash GenerationAlthough TTM operating and free cash flow improved, repeated negative cash flow in earlier years indicates that cash conversion can weaken materially. This uneven pattern may constrain internally funded growth and reduce flexibility if profitability or working-capital conditions deteriorate again.
Balance-sheet Execution RiskPeriods in which assets grow faster than equity can increase the need for efficient use of capital and sustained operating returns. Because profitability remains modest, any execution shortfall could weaken returns on the expanded asset base and reduce the current balance-sheet cushion.
NNH FAQ
What was New Nordic Healthbrands AB’s price range in the past 12 months?
New Nordic Healthbrands AB lowest stock price was kr11.60 and its highest was kr26.00 in the past 12 months.
What is New Nordic Healthbrands AB’s market cap?
New Nordic Healthbrands AB’s market cap is kr103.46M.
When is New Nordic Healthbrands AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were New Nordic Healthbrands AB’s earnings last quarter?
Currently, no data Available
Is New Nordic Healthbrands AB overvalued?
According to Wall Street analysts New Nordic Healthbrands AB’s price is currently Overvalued.
Does New Nordic Healthbrands AB pay dividends?
New Nordic Healthbrands AB pays a Notavailable dividend of kr0.25 which represents an annual dividend yield of 1.5%. See more information on New Nordic Healthbrands AB dividends here
What is New Nordic Healthbrands AB’s EPS estimate?
New Nordic Healthbrands AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does New Nordic Healthbrands AB have?
New Nordic Healthbrands AB has 6,195,200 shares outstanding.
What happened to New Nordic Healthbrands AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of New Nordic Healthbrands AB?
Currently, no hedge funds are holding shares in SE:NNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
New Nordic Healthbrands AB
New Nordic Healthbrands AB (publ)., engages in providing dietary supplements, natural medicines and cosmetic products for various health and beauty needs in the Nordic countries, Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and men health; skincare products comprising dietary supplements, facial care, and body care, as well as assortment products; hair care products, such as hair volume products, dietary supplements, shampoos, conditioners, serum, and other hair care products; and weight loss products. The company sells its products through pharmacies, health stores,beauty stores, and travel retailers, as well as through online stores. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
Technical Analysis
Zinzino AB
―
Midsona AB Class B
―
Arctic Blue Beverages AB
―
Enzymatica AB
―
Generic Sweden AB
―